📖

TREM2 Gene

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-entities-trem2
Related Entities
entities-trem2
Metadata
slugentities-trem2
entity_typegene
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (204)
related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia90%
targets🧪TREM2 Conformational Stabilizers for Synaptic Discrimination90%
targets🧪APOE-TREM2 Interaction Modulation90%
targets🧪TREM2-Mediated Selective Aggregate Clearance Pathway90%
targets🧪TREM2-Dependent Microglial Senescence Transition90%
targets🧪TREM2-mediated microglial tau clearance enhancement90%
targets🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia90%
mentions🧪TREM2-mediated microglial tau clearance enhancement86%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination83%
analysis_target🔬What are the mechanisms underlying protein aggregation cross80%
analysis_target🔬What are the mechanisms underlying mechanistic role of apoe 80%
analysis_target🔬What are the mechanisms underlying synaptic pruning by micro80%
analysis_target🔬What gene expression changes in the aging mouse brain predic80%
analysis_target🔬Investigate prion-like spreading of tau pathology through co80%
analysis_target🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas80%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination80%
mentions🧪TREM2-mediated microglial tau clearance enhancement80%
related🧪TREM2-mediated microglial tau clearance enhancement77%
mentions🔬Immune atlas neuroinflammation analysis in neurodegeneration75%
mentions🔬Neuroinflammation and microglial priming in early Alzheimer&75%
mentions🔬Neuroinflammation and microglial priming in early AD — Analy75%
mentions🔬Does SYK activation provide neuroprotection or exacerbate ne75%
mentions🔬What are the optimal timing windows for TREM2 agonism vs ant75%
mentions🔬Analysis question not specified75%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination74%
mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia70%
mentions🧫s:** - GPR32 knockout in microglia should worsen neuroinflam70%
mentions🧫Proposed experiment from debate on Synaptic pruning by micro70%
mentions🧫Proposed experiment from debate on Synaptic pruning by micro70%
mentions🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional70%
mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi70%
mentions🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti70%
mentions🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy70%
mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%
mentions🧫Experiment: Autoimmune Hypothesis Testing in AD70%
mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring70%
mentions🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi70%
mentions🧫DLB Cognitive Fluctuation Mechanism Experiment70%
mentions🧫Genetic Risk Modifiers in DLB Phenotype70%
mentions🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras70%
mentions🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud70%
mentions🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation70%
mentions🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr70%
mentions🧫Microglial Contributions to Huntington's Disease Pathog70%
mentions🧫Mixed Pathology Effects on Parkinson's Disease Progress70%
mentions🧫Prodromal Parkinson's Disease Biomarker Development — E70%
mentions🧫Progranulin Replacement Therapy for FTD — Vector Development70%
mentions🧫PSP and CBS Biomarker Validation Study70%
mentions🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo70%
mentions🧫Experiment Validation: In vitro ThT Assay70%
mentions🧫Tau ASO Therapy70%
mentions🧫Microglial TREM2 Agonist In Vivo Efficacy70%
mentions🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim70%
mentions🧫TREM2 Function in Alzheimer's Disease — From Risk Varia70%
mentions🧫TREM2 KO amyloid pathology study70%
mentions🧫TREM2 KO amyloid pathology study70%
mentions🧫TREM2 KO amyloid pathology study70%
mentions🧫TREM2 KO amyloid pathology study70%
mentions🧫TREM2 KO amyloid pathology study70%
mentions🧫TREM2 KO amyloid pathology study70%
mentions🧫TREM2 KO amyloid pathology study70%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 70%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 70%
related🧫Microglial TREM2 Agonist In Vivo Efficacy70%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim70%
related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia70%
related🧪APOE-TREM2 Interaction Modulation70%
related🔬Immune atlas neuroinflammation analysis in neurodegeneration67%
related🔬Neuroinflammation and microglial priming in early Alzheimer&67%
related🔬Neuroinflammation and microglial priming in early AD — Analy67%
related🔬Does SYK activation provide neuroprotection or exacerbate ne67%
related🔬What are the optimal timing windows for TREM2 agonism vs ant67%
related🔬Analysis question not specified67%
mentions🧪Multi-Modal CRISPR Platform for Simultaneous Editing and Mon65%
related🧫s:** - GPR32 knockout in microglia should worsen neuroinflam63%
related🧫Proposed experiment from debate on Synaptic pruning by micro63%
related🧫Proposed experiment from debate on Synaptic pruning by micro63%
related🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional63%
related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi63%
related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti63%
related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy63%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri63%
related🧫Experiment: Autoimmune Hypothesis Testing in AD63%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring63%
related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi63%
related🧫DLB Cognitive Fluctuation Mechanism Experiment63%
related🧫Genetic Risk Modifiers in DLB Phenotype63%
related🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras63%
related🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud63%
related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation63%
related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr63%
related🧫Microglial Contributions to Huntington's Disease Pathog63%
related🧫Mixed Pathology Effects on Parkinson's Disease Progress63%
related🧫Prodromal Parkinson's Disease Biomarker Development — E63%
related🧫Progranulin Replacement Therapy for FTD — Vector Development63%
related🧫PSP and CBS Biomarker Validation Study63%
related🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo63%
related🧫Experiment Validation: In vitro ThT Assay63%
related🧫Tau ASO Therapy63%
related🧫Microglial TREM2 Agonist In Vivo Efficacy63%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim63%
related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia63%
related🧫TREM2 KO amyloid pathology study63%
related🧫TREM2 KO amyloid pathology study63%
related🧫TREM2 KO amyloid pathology study63%
related🧫TREM2 KO amyloid pathology study63%
related🧫TREM2 KO amyloid pathology study63%
related🧫TREM2 KO amyloid pathology study63%
related🧫TREM2 KO amyloid pathology study63%
mentions🧪APOE-TREM2 Interaction Modulation60%
mentions🧪TREM2-Mediated Selective Aggregate Clearance Pathway60%
mentions🧪TREM2-Dependent Microglial Senescence Transition60%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR60%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR60%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen60%
related🧪Multi-Modal CRISPR Platform for Simultaneous Editing and Mon58%
related🧪APOE-TREM2 Interaction Modulation54%
related🧪TREM2-Mediated Selective Aggregate Clearance Pathway54%
related🧪TREM2-Dependent Microglial Senescence Transition54%
related🔬The disease-associated microglia (DAM) phenotype involves TR54%
related🔬The disease-associated microglia (DAM) phenotype involves TR54%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen54%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
mentions🧪APOE Isoform Expression Across Glial Subtypes50%
mentions🧪CYP46A1 Overexpression Gene Therapy50%
mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🔬What are the most promising therapeutic strategies for targe50%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
related🧪APOE Isoform Conversion Therapy50%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
see_also📖sTREM2 (Soluble TREM2) - Microglial Biomarker50%
see_also📖sTREM2 (Soluble TREM2) - Biomarker50%
see_also📖TREM2-Deficient Microglia50%
see_also📖TREM2-Expressing Microglia50%
see_also📖al002-trem2-agonist-alzheimers50%
see_also📖AD Neuroimmune Checkpoint and TREM2 Pathway Companies50%
see_also📖PD TREM2 Targeting Companies50%
see_also📖TREM2 Variants in Alzheimer's Disease50%
see_also📖TREM2 Protein (Triggering Receptor Expressed on Myeloid Cell50%
see_also📖Microglial TREM2 Agonist In Vivo Efficacy50%
see_also📖TREM2 Agonist Therapy for Parkinson's Disease — Experim50%
see_also📖TREM2 Function in Alzheimer's Disease — From Risk Varia50%
see_also📖TREM2 — Triggering Receptor Expressed on Myeloid Cells 250%
see_also📖trem2-alpha-synuclein-clearance-parkinsons50%
see_also📖sTREM2-Modulated Microglial Therapy50%
see_also📖Microglia-State Editing via TREM2-LXR Pulse Program50%
see_also📖Microglia-State Editing via TREM2-LXR Pulse Program50%
see_also📖TREM1-TREM2 Balanced Microglial Modulation Therapy50%
see_also📖TREM2 Microglial Priming Inhibitor for Pre-Symptomatic Neuro50%
see_also📖TREM2 Therapeutics Investment Landscape50%
see_also📖TREM2-APOE Axis in Neurodegeneration50%
see_also📖TREM2 Microglial Signaling Pathway in Neurodegeneration50%
see_also📖TREM2 Signaling in Neurodegeneration50%
see_also📖TREM2 Protein50%
see_also📖TREM2 Protein — Triggering Receptor Expressed on Myeloid Cel50%
see_also📖TREM2 Agonist Therapy for Neurodegeneration50%
see_also📖TREM2 Modulator Therapy50%
see_also📖TREM2-Targeting Therapies50%
see_also📖trem2-therapeutics50%
see_also📖Microglia in Alzheimer's Disease Neurodegeneration45%
see_also📖Microglia in Alzheimer's Disease Neurodegeneration45%
see_also📖AAIC 2026: Cellular Pathophysiology and Neurodegeneration Bi45%
see_also📖Cholecalciferol (Vitamin D3) as TREM2 Agonist45%
see_also📖MS4A4A/MS4A6A → TREM2 Negative Regulation → Microglial Dysfu45%
see_also📖MS4A4A-MS4A6A Cooperation in TREM2 Regulation45%
see_also📖Neuroimmune Genes in Alzheimer's Disease — TREM2, CD33,45%
see_also📖TREM2 in Amyotrophic Lateral Sclerosis45%
see_also📖TREM2-Mediated Amyloid Clearance Pathway45%
see_also📖TREM2+ Border-Associated Macrophages45%
see_also📖TREM2 Inflammatory Cytokine Regulation45%
see_also📖TREM2 in Frontotemporal Dementia45%
see_also📖TREM2 Gene-Mechanism-Therapy Chain — From Genetic Risk to Th45%
see_also📖TREM2 in ALS45%
see_also📖TREM2 in FTD45%
see_also📖TREM2 Lipid Sensing in Microglia45%
see_also📖TREM2 Microglia Pathway in Alzheimer's Disease45%
see_also📖TREM2→Microglial Dysfunction→Alzheimer's Disease Causal45%
see_also📖TREM2 in Parkinson's Disease — Cross-Disease Therapeuti45%
see_also📖TREM2-SYK Signaling Cascade45%
see_also📖Microglial Modulation Therapy for Neurodegeneration45%
see_also📖Neuroinflammation Modulation Therapy: GFAP and sTREM2-Target45%
see_also📖TREM2 Agonist Therapies for Alzheimer's Disease45%
see_also📖TREM2 Agonists in Alzheimer Disease45%
mentions📖Diaxa Group40%
mentions📖Johns Hopkins University40%
mentions🔬What are the most promising therapeutic strategies for targe40%
related🧪CYP46A1 Overexpression Gene Therapy40%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th40%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination35%
related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia35%